Previous close | 243.51 |
Open | 246.26 |
Bid | 241.51 x 1000 |
Ask | 247.26 x 800 |
Day's range | 244.02 - 247.10 |
52-week range | 198.64 - 258.45 |
Volume | |
Avg. volume | 3,313,512 |
Market cap | 131.109B |
Beta (5Y monthly) | 0.57 |
PE ratio (TTM) | 24.25 |
EPS (TTM) | 10.12 |
Earnings date | 01 Aug 2022 - 05 Aug 2022 |
Forward dividend & yield | 7.76 (3.25%) |
Ex-dividend date | 16 May 2022 |
1y target est | 250.03 |
In the latest trading session, Amgen (AMGN) closed at $243.51, marking a -0.55% move from the previous day.
Amgen (AMGN) closed the most recent trading day at $244.85, moving -0.21% from the previous trading session.
Let's look at two companies that fit the bill: Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT). Biotech Amgen has been around since 1980, and in that time the company has survived several recessions. In the first quarter, Amgen's revenue increased by a respectable 6% year over year to $6.2 billion.